Investor Relations

A Leader In Venture Debt and Equipment Financing

330

Investments
Since Inception *
Q1'24

187

Exits
Since Inception *
Q1'24

$1.6B

Assets Under
Management
Q1'24

*January 2008

Corporate Profile

Trinity, an internally managed specialty lending company that has elected to be regulated as a BDC under the Investment Company Act of 1940, is a leading provider of debt and equipment financing to growth stage companies, including venture-backed companies and companies with institutional equity investors. Trinity’s investment objective is to generate current income and, to a lesser extent, capital appreciation through investments consisting primarily of term debt and equipment financings and, to a lesser extent, working capital loans, equity and equity-related investments. Trinity believes it is one of only a select group of specialty lenders that has the depth of knowledge, experience, and track record in lending to growth stage companies.


Recent SEC Filings

Latest Quarterly Results

Latest News

Jun 13, 2024

Trinity Capital Inc. Declares Cash Dividend of $0.51 per Share for the Second Quarter of 2024

18th Consecutive Quarter of a Consistent or Increased Dividend PHOENIX , June 13, 2024 /PRNewswire/ --  Trinity Capital Inc.  (Nasdaq: TRIN) (" Trinity Capital " or the "Company"), a leading provider of diversified financial solutions to growth stage companies, today announced that on June 13, 2024

Jun 05, 2024

Trinity Capital Inc. Exits Its Equity Position in Core Scientific

Liquidation of shares results in a return of 17.7% on the initial investment PHOENIX , June 5, 2024 /PRNewswire/ --  Trinity Capital Inc. (Nasdaq: TRIN) ("Trinity" or the "Company"), a leading provider of diversified financial solutions to growth-stage companies, announced today that as of June 4,

Jun 05, 2024

Trinity Capital Inc. Provides $15 Million in Growth Capital to restor3d

PHOENIX , June 5, 2024 /PRNewswire/ --  Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-oriented companies, today announced the commitment of $15 million in growth capital to restor3d , a 3D printing, patient specific medical device